Interní Med. 2009; 11(3): 123-125

Complex approach to patients at high cardiovascular risk from the perspective of an internist

MUDr. Pavel Havránek
Interní oddělení Nemocnice České Budějovice

The paper presents the diagnostic options in identifying patients at high cardiovascular risk. It deals with the significance of both classic and new risk factors. The author discusses the options of nonpharmacological as well as pharmacological treatment aimed at reducing the established high risk. Current principles of intervention with hypolipidemic drugs, antihypertensives, and antiplatelet drugs are dealt with in detail.

Keywords: risk factor, hypertension, statin.

Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Havránek P. Complex approach to patients at high cardiovascular risk from the perspective of an internist. Interní Med. 2009;11(3):123-125.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Barrios V, et al. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study. J Hum Hypertens. 2007; 21: 1413-1426. Go to original source... Go to PubMed...
    2. Deepak L. Identification of and Management Approaches for the High-Risk Patient. Am J Cardiol 2006; 98 (suppl) 22Q-29Q. Go to original source... Go to PubMed...
    3. Fletcher Gerald F. Efficacy of Drug Therapy in the Secondary Prevention of Cardiovascular Disease and Stroke, Am J Cardiol 2007; 99. Go to original source... Go to PubMed...
    4. Guidelines on CVD prevention, Eu J Card Prev Rehab.; 2003; 10: S1-78.
    5. Giuseppe MC, et al. Metabolic Therapy for Patients with Diabetes Mellitus and Coronary Artery Disease. Am J Cardiol 2006; 98 (suppl.): 14J-18J. Go to original source... Go to PubMed...
    6. Grundy Scott M. Cardiovascular and Metabolic Risk Factors: How Can We Improve Outcomes in the High-Risk Patient? Am J Med. 2007; 120 (9A): 53-59. Go to original source... Go to PubMed...
    7. Friedewald VE, et al. Lipid management Beyond Statins - Reducing Residual Cardiovascular Risk. Am J Cardiol 2008; 102: 559-567. Go to original source... Go to PubMed...
    8. Hlatky M. Expanding the Orbit of Primary Prevention - Moving beyond JUPITER, N Engl J Med; 359: 2195-2207. Go to original source...
    9. Khosla N, et al. Microalbuminuria. Clin Lab Med 2006; 26: 635-653. Go to original source... Go to PubMed...
    10. Mitka M. Heart disease, a global health threat. JAMA 2004; 291: 2533. Go to original source... Go to PubMed...
    11. Patrick E, et al. Assessment and Management of Cardiovascular Risk in Men. Prim Care Clin Office Pract 2006; 33: 75-91. Go to original source... Go to PubMed...
    12. Ragavendra R, et al. Applying Hypertension Guidelines to Reduce the Burden of Heart Failure. Cardiol Clin 2007; 25: 507-522. Go to original source... Go to PubMed...
    13. Ramasubbu K, et al. Anti-angiotensin Therapy: New Perspectives. Cardiol Clin 2007; 25: 573-580. Go to original source... Go to PubMed...
    14. Rosenzweig JL. Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2008; 93 (10): 3671-3689. Go to original source... Go to PubMed...
    15. Virani SS. Does Preoperative Statin Therapy Improve Outcomes in Patients Undergoing Isolated Cardiac Valve Surgery? Am J Cardiol 2008; 102: 1235-1239. Go to original source... Go to PubMed...
    16. Zannad F. Cardiovascular High-Risk Patients - Treat to Protect, But Whom? Medscape J Med. 2008; 10 (Supp): S2.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.